South Africa
#Covid19: SAHPRA to control access to Ivermectin─── 14:56 Wed, 27 Jan 2021
The South African Health Products Regulatory Authority (SAHPRA) has resolved to facilitate controlled access to Ivermectin for COVID-19 treatment.
SAHPRA says it will be engaging with medical professionals and a guideline will be published soon.
There has been much debate around the use of the drug. South Africa's COVID-19 death toll is 41,797. Confirmed COVID-19 cases are now over 1.4 million.
BREAKING: @SAHPRA1 has resolved to facilitate a controlled access programme of the ivermectin.
— @SAgovnews (@SAgovnews) January 27, 2021
.@SAHPRA1 CEO Boitumelo Semete says the will have healthcare practitioners reporting to us on rollout. She says studies are saying “we cannot prove that there is risk or there is significant benefit, we’ve considered that. The framework will be communicated and will be revolving”
— @SAgovnews (@SAgovnews) January 27, 2021
